,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,BioPlanet_2019,Oncostatin M,25 of 311,5.076164484627875e-16,3.659914593416698e-13,0,0,10.036507610037022,353.453736745178,CXCL8;CEBPD;EPAS1;HIF1A;ICAM1;SOCS3;MT2A;SOCS1;KIF5B;NAMPT;CASP4;ITGAV;TIMP1;B2M;JUNB;LDLR;IER3;TGM2;IL13RA1;SERPINB1;STAT3;SOD2;IRF1;LCN2;ATF3
1,BioPlanet_2019,BDNF signaling pathway,18 of 261,9.881383477252532e-11,2.9145587057862762e-08,0,0,8.186649926762922,188.6022685450587,TMOD1;BTG2;BTG1;GCH1;IGFBP4;ARPC1B;SLC39A14;SLC7A5;ZFP36;PPP2R1B;SPP1;CALR;TIMP1;KCNK1;JUNB;CLIC1;ATF3;S100A11
2,BioPlanet_2019,Prolactin activation of MAPK signaling,11 of 75,1.6218421580134012e-10,2.9145587057862762e-08,0,0,18.44013247282609,415.6827823482107,SOCS2;NFKBIA;SOCS3;PTPN1;STAT5B;SOCS1;IRF1;STAT3;MAPK14;YWHAZ;JAK1
3,BioPlanet_2019,Interferon-gamma signaling pathway,12 of 97,1.816319932030734e-10,2.9145587057862762e-08,0,0,15.21311475409836,341.21553639151256,SOCS3;PTPN1;MT2A;SOCS1;IFNGR2;IRF1;STAT3;IFI30;B2M;ICAM1;HLA-E;JAK1
4,BioPlanet_2019,Interleukin-2 signaling pathway,31 of 847,2.0211918902817448e-10,2.9145587057862762e-08,0,0,4.398755081300813,98.18973033169485,BTG1;CXCL8;SMARCD3;CTSS;ICAM1;SOCS2;SOCS3;SLC9A3R1;MT2A;GNG10;ZFP36;SOCS1;NAMPT;FLOT1;APBB2;LDLR;S100A11;IER3;JAK1;STAT5B;WARS;ACTN1;STAT3;MAPK14;ATP1B1;SLC7A5;BCL6;IRF1;TAX1BP3;TOP1;BIRC3
5,BioPlanet_2019,Interleukin-5 regulation of apoptosis,13 of 144,1.6598285695854372e-09,1.994560664451834e-07,0,0,10.727371864776446,216.8704658845321,CXCL8;INHBA;MAPK14;SOD2;HIF1A;IL17RB;ICAM1;NFKB2;SOCS1;CASP4;IER3;NFE2L2;BIRC3
6,BioPlanet_2019,Interleukin-1 regulation of extracellular matrix,12 of 120,2.2103163486432604e-09,2.2766258391025587e-07,0,0,11.959319975713418,238.35080406967975,NFKBIA;MT2A;ZFP36;CXCL8;NAMPT;ID1;SPP1;INHBA;ACPP;SOD2;ICAM1;BIRC3
7,BioPlanet_2019,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",16 of 280,1.673570731004806e-08,1.5083056213180814e-06,0,0,6.616218046385645,118.46815598748786,STAT5B;PTPN1;IFNGR2;STAT3;IFI30;YWHAZ;HLA-E;ICAM1;NFKB2;SOCS2;SOCS3;MT2A;SOCS1;IRF1;B2M;JAK1
8,BioPlanet_2019,Interleukin-6 signaling pathway,9 of 71,2.9259394686319937e-08,2.3440026187596305e-06,0,0,15.408168574401666,267.2865037784577,SOCS3;CEBPD;IRF1;STAT3;TIMP1;MAPK14;JUNB;JAK1;HSP90B1
9,BioPlanet_2019,Immune system,30 of 998,3.7830409471490266e-08,2.727572522894448e-06,0,0,3.538129226145755,60.467168302673606,IFI30;CTSS;ICAM1;HSP90B1;SOCS2;SOCS3;MT2A;SOCS1;PPP2R1B;KIF5B;CASP4;ITGAV;B2M;JAK1;STAT5B;PTPN1;IFNGR2;STAT3;MAPK14;YWHAZ;HLA-E;NFKB2;TAPBP;NFKBIA;IRF1;PSME1;PSME2;CALR;CFB;BIRC3
10,BioPlanet_2019,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",11 of 135,8.920256572899135e-08,5.8468227173275246e-06,0,0,9.488560659186536,154.0216948700854,NFKBIA;DDR1;CXCL8;IFNGR2;IRF1;INHBA;SOD2;ICAM1;NFKB2;RND1;BIRC3
11,BioPlanet_2019,Interferon gamma signaling regulation,5 of 14,1.5601160529384307e-07,9.373697284738402e-06,0,0,57.88304093567251,907.220316846268,PTPN1;SOCS3;SOCS1;IFNGR2;JAK1
12,BioPlanet_2019,FSH regulation of apoptosis,14 of 263,3.221177384053277e-07,1.7865145337710863e-05,0,0,6.074774235061794,90.8078436063818,PTPN1;IGFBP4;ACTN1;ECEL1;RAB27A;MAPK14;PAPSS2;VGF;CASP4;S100A6;TIMP1;ACPP;LDLR;IER3
13,BioPlanet_2019,T cell receptor regulation of apoptosis,21 of 603,4.862509246305868e-07,2.504192261847522e-05,0,0,3.986283919895722,57.94677980049653,SERPINB1;BTG1;CXCL8;GADD45B;CEBPD;EPAS1;PRUNE2;MAPK14;SOD2;HSP90B1;NFKBIA;IRF1;NAMPT;CASP4;PSME1;S100A6;PSME2;JUNB;ATF3;IER3;BIRC3
14,BioPlanet_2019,Adipogenesis,10 of 133,7.357826528750945e-07,3.4722478070363364e-05,0,0,8.649527576356844,122.15149203606762,SOCS3;STAT5B;SOCS1;GADD45B;CEBPD;EPAS1;NAMPT;STAT3;HIF1A;AGPAT2
15,BioPlanet_2019,Interferon signaling,11 of 168,8.137217655440718e-07,3.4722478070363364e-05,0,0,7.481584048739961,104.90413308157946,SOCS3;PTPN1;MT2A;SOCS1;IFNGR2;IRF1;IFI30;B2M;ICAM1;HLA-E;JAK1
16,BioPlanet_2019,Interleukin-4 signaling pathway,9 of 104,8.186992055425481e-07,3.4722478070363364e-05,0,0,10.03904923599321,140.70278739356158,NFKBIA;SOCS3;STAT5B;SOCS1;BCL6;STAT3;MAPK14;IL13RA1;JAK1
17,BioPlanet_2019,Antigen processing: cross presentation,8 of 79,1.0209666918802977e-06,4.089538804698304e-05,0,0,11.890637945318971,164.02850434051769,PSME1;PSME2;ITGAV;CALR;B2M;CTSS;HLA-E;TAPBP
18,BioPlanet_2019,Antigen processing and presentation,8 of 81,1.2379825382196789e-06,4.697817947665202e-05,0,0,11.563694967401656,157.28969681675255,PSME1;PSME2;CALR;IFI30;B2M;CTSS;HLA-E;TAPBP
19,BioPlanet_2019,Leptin signaling pathway,7 of 61,2.1019430722164827e-06,7.577504775340419e-05,0,0,13.618695823483058,178.03242173865593,SOCS2;SOCS3;PTPN1;STAT5B;STAT3;MAPK14;JAK1
20,BioPlanet_2019,Growth hormone receptor signaling,6 of 43,3.591292303219408e-06,0.00012330103574386637,0,0,16.96096096096096,212.63954123054023,SOCS2;SOCS3;PTPN1;STAT5B;SOCS1;STAT3
21,BioPlanet_2019,Gastrin pathway,6 of 44,4.124816855494184e-06,0.00013336277954946205,0,0,16.51378446115288,204.74597396333533,CHGA;CXCL8;S100A6;ITGAV;IER3;BIRC3
22,BioPlanet_2019,Jak-STAT signaling pathway,11 of 199,4.254291164545945e-06,0.00013336277954946205,0,0,6.2380608233117485,77.14973124005023,SOCS2;STAT5B;SOCS3;PTPN1;PTP4A3;SOCS1;CXCL8;IFNGR2;STAT3;JAK1;IL13RA1
23,BioPlanet_2019,Interleukin-22 soluble receptor signaling pathway,4 of 13,5.848327506924216e-06,0.000175693505520515,0,0,46.06399069226294,555.0413689141894,STAT5B;SOCS3;STAT3;JAK1
24,BioPlanet_2019,Type II interferon signaling (interferon-gamma),6 of 50,8.845454195687575e-06,0.0002551028990036297,0,0,14.257575757575758,165.8955465928339,SOCS3;SOCS1;IFNGR2;IRF1;ICAM1;JAK1
25,BioPlanet_2019,Interleukin-4 regulation of apoptosis,12 of 267,1.2872364609781576e-05,0.00035696057244817374,0,0,5.027322404371585,56.60980107671765,TMOD1;CXCL8;NNMT;GADD45B;BCL6;ACTN1;SPP1;ARID5B;INHBA;ELL2;HS3ST1;IL13RA1
26,BioPlanet_2019,Interferon alpha/beta signaling,6 of 64,3.72707296967961e-05,0.0009952665226440735,0,0,10.808429118773946,110.21681874478548,SOCS3;PTPN1;SOCS1;IRF1;JAK1;HLA-E
27,BioPlanet_2019,PDGFB signaling pathway,8 of 129,3.940115409376298e-05,0.0010126549622446,0,0,6.959473195739603,70.58099683566478,SLC9A3R1;STAT5B;PTPN1;ARPC1B;STAT3;ITGAV;YWHAZ;YWHAH
28,BioPlanet_2019,Interleukin-12-mediated signaling events,6 of 65,4.073092081150355e-05,0.0010126549622446,0,0,10.624697336561743,107.39999770132724,SOCS1;GADD45B;STAT3;MAPK14;B2M;NFKB2
29,BioPlanet_2019,Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),5 of 42,5.311569924249058e-05,0.0012765473051278,0,0,14.059743954480796,138.39059428317788,PTPN1;STAT5B;ITGA1;STAT3;JAK1
30,BioPlanet_2019,Hemostasis pathway,15 of 468,5.821834723994024e-05,0.0013540460761289,0,0,3.559970566593083,34.714376615035924,PTPN1;ACTN1;H3F3A;MAPK14;ATP1B1;YWHAZ;SLC7A5;GNG10;GNG5;PPP2R1B;TMSB4X;KIF5B;IRF1;ITGAV;TIMP1
31,BioPlanet_2019,Diabetes pathways,8 of 137,6.046806369658211e-05,0.0013567803380906,0,0,6.525224889109978,63.38208814998303,CXCL8;IGFBP4;KIF5B;RAB27A;HDGF;CALR;ATF3;HSP90B1
32,BioPlanet_2019,AP-1 transcription factor network,6 of 70,6.209951616781197e-05,0.0013567803380906,0,0,9.792162698412698,94.85445097389598,MT2A;CXCL8;TIMP1;JUNB;HIF1A;ATF3
33,BioPlanet_2019,Endosomal/vacuolar pathway,3 of 9,7.34205724789232e-05,0.0015569480222736,0,0,51.559895833333336,490.8144454929683,B2M;CTSS;HLA-E
34,BioPlanet_2019,Interferon alpha signaling regulation,4 of 25,9.44095967986292e-05,0.0019448376940517,0,0,19.729743206182995,182.8526523345712,SOCS3;PTPN1;SOCS1;JAK1
35,BioPlanet_2019,Interleukin-9 regulation of target genes,4 of 26,0.00011072763243715492,0.0022176284163107,0,0,18.831984769157543,171.52994937618263,SOCS2;SOCS3;LCN2;JUNB
36,BioPlanet_2019,TWEAK regulation of gene expression,4 of 27,0.00012899773574962084,0.0024475623019862,0,0,18.012292283177782,161.3129689030519,CXCL8;TNFRSF12A;SPP1;ICAM1
37,BioPlanet_2019,Oxidative stress,4 of 27,0.00012899773574962084,0.0024475623019862,0,0,18.012292283177782,161.3129689030519,MAPK14;SOD2;JUNB;NFE2L2
38,BioPlanet_2019,TGF-beta regulation of extracellular matrix,16 of 565,0.00014004218107254758,0.0025623650844638,0,0,3.135167038088551,27.820114415523104,TNFRSF12A;CEBPD;PLOD2;INHBA;ATP1B1;SLC7A5;SDCBP;RRAS;ELF3;RBP1;LCN2;JUNB;SKIL;ATF3;S100A11;CFB
39,BioPlanet_2019,Erythropoietin-mediated neuroprotection through NF-kB,3 of 11,0.0001421561766692847,0.0025623650844638,0,0,38.666015625,342.52615776208006,NFKBIA;SOD2;HIF1A
40,BioPlanet_2019,Regular glucocorticoid receptor pathway,6 of 82,0.00015056072403948006,0.0026476654154259,0,0,8.241019214703424,72.5303974183046,STAT5B;CXCL8;IRF1;MAPK14;ICAM1;YWHAH
41,BioPlanet_2019,RANKL signaling pathway,5 of 54,0.0001796427590120848,0.0030079630909747,0,0,10.610096670247046,91.5072068637462,NFKBIA;MAPK14;PAPSS2;ICAM1;NFKB2
42,BioPlanet_2019,Kit receptor signaling pathway,5 of 54,0.0001796427590120848,0.0030079630909747,0,0,10.610096670247046,91.5072068637462,STAT5B;SOCS1;STAT3;MAPK14;JUNB
43,BioPlanet_2019,NOD signaling pathway,6 of 85,0.00018356501526059252,0.0030079630909747,0,0,7.926863572433192,68.19434475439361,NFKBIA;CXCL8;CASP4;MAPK14;BIRC3;HSP90B1
44,BioPlanet_2019,"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",10 of 255,0.00020982774969552207,0.0033619068340104,0,0,4.3154991726420295,36.54892745327419,SOCS3;SOCS1;PSME1;PSME2;ITGAV;CALR;B2M;CTSS;HLA-E;TAPBP
45,BioPlanet_2019,ATF2 transcription factor network,5 of 59,0.0002734091695507972,0.0042853915488288,0,0,9.625243664717347,78.97070719925709,SOCS3;CXCL8;MAPK14;JUNB;ATF3
46,BioPlanet_2019,Glucagon-type ligand receptors,4 of 33,0.00028734357804251345,0.0044079727610351,0,0,14.281278209063007,116.46142342857205,ADCYAP1;GNG10;GNG5;GCGR
47,BioPlanet_2019,RAGE pathway,5 of 60,0.0002959279292225085,0.0044450841035297,0,0,9.44976076555024,76.78303524351871,CXCL8;ID1;TIMP1;LDLR;ICAM1
48,BioPlanet_2019,Adaptive immune system,16 of 606,0.0003076533624236704,0.0045268994756625,0,0,2.911087965154815,23.54062011970401,IFI30;YWHAZ;CTSS;HLA-E;ICAM1;TAPBP;NFKBIA;SOCS3;SOCS1;PPP2R1B;KIF5B;PSME1;PSME2;ITGAV;CALR;B2M
49,BioPlanet_2019,Pathways in cancer,11 of 325,0.0003624611749325383,0.0052266901425272,0,0,3.7109007200221535,29.39995678449448,NFKBIA;STAT5B;CXCL8;EPAS1;STAT3;ITGAV;HIF1A;JAK1;HSP90B1;NFKB2;BIRC3
50,BioPlanet_2019,TSH regulation of gene expression,6 of 97,0.00037661306025887583,0.0053242748322872,0,0,6.877376591662306,54.22324705104303,VMP1;CXCL8;GADD45B;ID1;CALM2;ICAM1
51,BioPlanet_2019,Interleukin-10 anti-inflammatory signaling pathway,3 of 16,0.00046542611123970816,0.0063315514378081,0,0,23.78846153846154,182.5183319425426,STAT3;MAPK14;JAK1
52,BioPlanet_2019,Interleukin-9 signaling pathway,3 of 16,0.00046542611123970816,0.0063315514378081,0,0,23.78846153846154,182.5183319425426,STAT5B;STAT3;JAK1
53,BioPlanet_2019,TGF-beta signaling pathway,8 of 185,0.0004751561576963272,0.0063442146240565,0,0,4.744070817849482,36.30099919727271,STAT3;SPP1;INHBA;MAPK14;JUNB;SKIL;ATF3;JAK1
54,BioPlanet_2019,Chagas disease,6 of 104,0.0005467076318976923,0.0071668400472406,0,0,6.383867832847424,47.95303858164846,NFKBIA;CXCL8;PPP2R1B;IFNGR2;CALR;MAPK14
55,BioPlanet_2019,Calcium regulation in the cardiac cell,7 of 149,0.0006575849778731527,0.0084646585158468,0,0,5.155866047347917,37.77670343226943,GNG5;ANXA6;CALR;ATP1B1;CALM2;YWHAZ;YWHAH
56,BioPlanet_2019,Bioactive peptide-induced signaling pathway,4 of 41,0.0006691893694913607,0.0084646585158468,0,0,11.188906183670582,81.78467728963872,STAT5B;STAT3;MAPK14;CALM2
57,BioPlanet_2019,Signaling by interleukins,6 of 109,0.0007009333856991345,0.0087133270877426,0,0,6.072430266605024,44.104654320875575,SOCS3;STAT5B;STAT3;YWHAZ;NFKB2;JAK1
58,BioPlanet_2019,TWEAK signaling pathway,4 of 42,0.0007340395685267794,0.0089702123543696,0,0,10.893910168090382,78.62077908981352,NFKBIA;TNFRSF12A;MAPK14;NFKB2
59,BioPlanet_2019,"Platelet activation, signaling and aggregation",8 of 205,0.0009302438457075336,0.0111784302125855,0,0,4.258096039523331,29.721782050076875,PTPN1;GNG10;GNG5;ACTN1;TMSB4X;TIMP1;MAPK14;YWHAZ
60,BioPlanet_2019,Interleukin-3 signaling pathway,4 of 45,0.0009551352983592991,0.0112893860674927,0,0,10.095262418592773,70.19899777508158,STAT5B;CXCL8;STAT3;JAK1
61,BioPlanet_2019,Unfolded protein response,5 of 79,0.0010520079320614,0.0120139218283314,0,0,7.016714082503556,48.11399174971746,CXCL8;HDGF;CALR;ATF3;HSP90B1
62,BioPlanet_2019,Prolactin regulation of apoptosis,6 of 118,0.0010612364583731,0.0120139218283314,0,0,5.581916099773243,38.22675090465951,SOCS2;SOCS3;BCL6;FTH1;IRF1;IER3
63,BioPlanet_2019,p38 MK2 pathway,3 of 21,0.0010664230194358,0.0120139218283314,0,0,17.17621527777778,117.54448805209928,MAPK14;YWHAZ;YWHAH
64,BioPlanet_2019,Innate immune system,10 of 319,0.0011964972476075,0.0132719156234626,0,0,3.410478439604653,22.94691631530951,NFKBIA;PPP2R1B;IRF1;CASP4;MAPK14;CFB;CTSS;HSP90B1;NFKB2;BIRC3
65,BioPlanet_2019,HES/HEY pathway,4 of 48,0.0012193283990237,0.0133202390256992,0,0,9.40552118039029,63.10592171725202,STAT3;ID1;RBBP8;HIF1A
66,BioPlanet_2019,FoxO family signaling,4 of 49,0.0013176984725826,0.0141800089363002,0,0,9.196044211751015,60.9869572711669,BCL6;SOD2;YWHAZ;YWHAH
67,BioPlanet_2019,Interleukin-11 pathway,3 of 23,0.0013998204927834,0.0146271097869115,0,0,15.45703125,101.5745093573338,SOCS3;TIMP1;ICAM1
68,BioPlanet_2019,Modulation of interferon signaling by chaperones,3 of 23,0.0013998204927834,0.0146271097869115,0,0,15.45703125,101.5745093573338,NFKBIA;IFNGR2;TAX1BP3
69,BioPlanet_2019,Integrin cell surface interactions,5 of 85,0.0014608711873271,0.0150469732294691,0,0,6.488486842105263,42.36152885331209,PTPN1;ITGA1;SPP1;ITGAV;ICAM1
70,BioPlanet_2019,mRNA stability regulation by proteins that bind AU-rich elements,5 of 86,0.0015389653276779,0.0156144172730506,0,0,6.408057179987004,41.5027111965236,ZFP36;PSME1;PSME2;MAPK14;YWHAZ
71,BioPlanet_2019,Plexin D1 signaling,3 of 24,0.0015883799229293,0.0156144172730506,0,0,14.720238095238097,94.87253361681506,RRAS;ITGA1;ITGAV
72,BioPlanet_2019,Insulin signaling pathway,9 of 277,0.0016371275368292,0.0156144172730506,0,0,3.5273832450649976,22.62750063272209,SOCS2;SOCS3;PTPN1;SOCS1;KIF5B;FLOT1;MAPK14;CALM2;RHOQ
73,BioPlanet_2019,Signaling events mediated by PTP1B,4 of 52,0.0016459025142189,0.0156144172730506,0,0,8.619982547993018,55.249488547449765,SOCS3;PTPN1;STAT5B;STAT3
74,BioPlanet_2019,Vitamin B12 metabolism,4 of 52,0.0016459025142189,0.0156144172730506,0,0,8.619982547993018,55.249488547449765,SOD2;LDLR;ICAM1;NFKB2
75,BioPlanet_2019,Interleukin-2 receptor beta chain in T cell activation,4 of 52,0.0016459025142189,0.0156144172730506,0,0,8.619982547993018,55.249488547449765,SOCS3;STAT5B;SOCS1;JAK1
76,BioPlanet_2019,HIF-1 degradation in normoxia,5 of 88,0.0017043078972798,0.0159585194018025,0,0,6.253012048192771,39.86042669092719,ID1;PSME1;PSME2;MAPK14;HIF1A
77,BioPlanet_2019,Thymic stromal lymphopoietin (TSLP) pathway,5 of 90,0.0018823251966838,0.0173994418821672,0,0,6.105263157894737,38.31203712182314,CXCL8;IRF1;PSME1;PSME2;ICAM1
78,BioPlanet_2019,Physiological and pathological hypertrophy  of the heart,3 of 26,0.0020114151539031,0.0183573458982806,0,0,13.438858695652174,83.44075482909811,STAT3;MAPK14;CALM2
79,BioPlanet_2019,Thromboxane A2 receptor signaling,4 of 56,0.0021664789937236,0.0195253919309341,0,0,7.9552960128876355,48.80297269773491,SLC9A3R1;MAPK14;ICAM1;TGM2
80,BioPlanet_2019,Insulin regulation of blood glucose,3 of 27,0.0022467184081044,0.0199985675585596,0,0,12.878255208333334,78.53526557511509,YWHAZ;RHOQ;YWHAH
81,BioPlanet_2019,Sema4D-mediated inhibition of cell attachment and migration,2 of 8,0.00254777710368,0.0224017962408944,0,0,34.19516407599309,204.2317809011976,RRAS;RND1
82,BioPlanet_2019,Toll-like receptor signaling pathway regulation,6 of 142,0.0027201557032863,0.0236293043622825,0,0,4.591269841269841,27.12093469452828,NFKBIA;SOCS1;CXCL8;SPP1;MAPK14;NFKB2
83,BioPlanet_2019,Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK),3 of 29,0.0027668426558877,0.0236724247785203,0,0,11.88641826923077,70.01157943508804,MAPK14;CALM2;YWHAH
84,BioPlanet_2019,Selenium pathway,4 of 60,0.0027907851680641,0.0236724247785203,0,0,7.385564697083022,43.437698766823125,SOD2;LDLR;ICAM1;NFKB2
85,BioPlanet_2019,Senescence and autophagy,5 of 99,0.0028555060696783,0.0239397660027682,0,0,5.518197088465845,32.32839182388039,MAP1LC3B;CXCL8;IRF1;INHBA;MAPK14
86,BioPlanet_2019,FGF signaling pathway,4 of 61,0.0029641864985643,0.0245652697179876,0,0,7.255625975934601,42.23610639379754,STAT5B;STAT3;SPP1;MAPK14
87,BioPlanet_2019,Tumor necrosis factor (TNF) pathway,3 of 30,0.0030523947920427,0.0246861727183626,0,0,11.445601851851851,66.29096665331821,NFKBIA;NFKB2;BIRC3
88,BioPlanet_2019,Shigellosis,4 of 62,0.0031448099461296,0.0246861727183626,0,0,7.130167900343023,41.08404042680444,NFKBIA;CXCL8;ARPC1B;MAPK14
89,BioPlanet_2019,"cAMP receptor, G-protein-independent pathways inferred from amoeba model",2 of 9,0.0032547398103224,0.0246861727183626,0,0,29.308660251665437,167.8695410270378,STAT5B;STAT3
90,BioPlanet_2019,Gene expression regulation by hypoxia-inducible factor,2 of 9,0.0032547398103224,0.0246861727183626,0,0,29.308660251665437,167.8695410270378,EPAS1;HIF1A
91,BioPlanet_2019,Folate metabolism,4 of 63,0.0033327993855406,0.0246861727183626,0,0,7.008962640873192,39.97872109250316,SOD2;LDLR;ICAM1;NFKB2
92,BioPlanet_2019,Prostaglandin biosynthesis and regulation,3 of 31,0.003355402117059,0.0246861727183626,0,0,11.036272321428571,62.875670333502086,ANXA2;ANXA6;S100A6
93,BioPlanet_2019,Alpha-V beta-3 integrin/OPN pathway,3 of 31,0.003355402117059,0.0246861727183626,0,0,11.036272321428571,62.875670333502086,NFKBIA;SPP1;ITGAV
94,BioPlanet_2019,Amino acid transport across the plasma membrane,3 of 31,0.003355402117059,0.0246861727183626,0,0,11.036272321428571,62.875670333502086,SLC7A5;SLC43A2;SLC7A2
95,BioPlanet_2019,Signal amplification,3 of 31,0.003355402117059,0.0246861727183626,0,0,11.036272321428571,62.875670333502086,GNG10;GNG5;MAPK14
96,BioPlanet_2019,CD40/CD40L signaling,3 of 31,0.003355402117059,0.0246861727183626,0,0,11.036272321428571,62.875670333502086,NFKBIA;MAPK14;BIRC3
97,BioPlanet_2019,NF-kappaB activation by non-typeable Hemophilus influenzae,3 of 31,0.003355402117059,0.0246861727183626,0,0,11.036272321428571,62.875670333502086,NFKBIA;CXCL8;MAPK14
98,BioPlanet_2019,EGFR1 pathway,6 of 152,0.0038056631675812,0.0276231273263371,0,0,4.274624918460535,23.815068257890243,BTG1;BCL6;LCN2;SPP1;ARID5B;IER3
99,BioPlanet_2019,ERBB1 downstream pathway,5 of 106,0.0038312243171064,0.0276231273263371,0,0,5.13392391870766,28.56808344489648,ZFP36;ARPC1B;STAT3;YWHAZ;YWHAH
100,BioPlanet_2019,Beta-1 integrin cell surface interactions,4 of 66,0.0039423815863347,0.028143139839083,0,0,6.668805944941733,36.91831147927381,ITGA1;SPP1;ITGAV;TGM2
101,BioPlanet_2019,Glucagon signaling in metabolic regulation,3 of 33,0.0040150785017677,0.0283810941154368,0,0,10.299479166666666,56.82941950918719,GNG10;GNG5;GCGR
102,BioPlanet_2019,G alpha 13 pathway,4 of 67,0.0041612456168037,0.0290232205605605,0,0,6.562619463143023,35.97589153695952,NFKBIA;ARHGEF10L;SLC9B2;NFKB2
103,BioPlanet_2019,Myometrial relaxation and contraction pathways,6 of 155,0.0041864284858506,0.0290232205605605,0,0,4.1879194630872485,22.932658753662466,GNG5;IGFBP4;CALM2;YWHAZ;ATF3;YWHAH
104,BioPlanet_2019,EPO receptor signaling,3 of 34,0.004372359516556,0.0300235353470179,0,0,9.966733870967742,54.14380813930872,STAT5B;SOCS1;STAT3
105,BioPlanet_2019,NFAT involvement in hypertrophy of the heart,4 of 69,0.0046233000436324,0.0314086137642663,0,0,6.360048328634716,34.195731800428526,CALR;MAPK14;CALM2;YWHAH
106,BioPlanet_2019,Toll receptor cascades,6 of 159,0.0047370432084561,0.0314086137642663,0,0,4.0776014109347445,21.82471783577686,NFKBIA;PPP2R1B;MAPK14;CTSS;HSP90B1;NFKB2
107,BioPlanet_2019,fMLP induced chemokine gene expression in HMC-1 cells,3 of 35,0.0047483202500763,0.0314086137642663,0,0,9.65478515625,51.652756441515024,NFKBIA;MAPK14;CALM2
108,BioPlanet_2019,Interleukin-7 signaling pathway,3 of 35,0.0047483202500763,0.0314086137642663,0,0,9.65478515625,51.652756441515024,STAT5B;STAT3;JAK1
109,BioPlanet_2019,BTG family proteins and cell cycle regulation,2 of 11,0.0049091189399834,0.0321770432338914,0,0,22.79332181922856,121.18436050948772,BTG2;BTG1
110,BioPlanet_2019,RIG-I-like receptor signaling pathway,4 of 71,0.0051186806516729,0.0331095555826709,0,0,6.169570993201532,32.54361435488265,NFKBIA;CXCL8;TMEM173;MAPK14
111,BioPlanet_2019,GM-CSF-mediated signaling events,3 of 36,0.0051432319351721,0.0331095555826709,0,0,9.361742424242424,49.33707174934982,STAT5B;STAT3;YWHAZ
112,BioPlanet_2019,Leishmaniasis,4 of 72,0.0053791960273722,0.034322126864915,0,0,6.0785340314136125,31.761655424830632,NFKBIA;IFNGR2;MAPK14;JAK1
113,BioPlanet_2019,Interleukin-23-mediated signaling events,3 of 37,0.0055573524467772,0.0351478167905826,0,0,9.0859375,47.17994310309933,NFKBIA;SOCS3;STAT3
114,BioPlanet_2019,Activation of chaperones by ATF6 alpha,2 of 12,0.0058533103841373,0.0363813516117499,0,0,20.51295336787565,105.45192195191358,CALR;HSP90B1
115,BioPlanet_2019,Toll-like receptor endosomal trafficking and processing,2 of 12,0.0058533103841373,0.0363813516117499,0,0,20.51295336787565,105.45192195191358,CTSS;HSP90B1
116,BioPlanet_2019,Disease,14 of 674,0.0064807044300129,0.0399366486670031,0,0,2.2436798928511634,11.30573709627622,STAT5B;CXCL8;IGFBP4;H3F3A;STAT3;RAB27A;HSP90B1;KIF5B;PSME1;PSME2;HDGF;CALR;B2M;ATF3
117,BioPlanet_2019,CTL mediated immune response against target cells,2 of 13,0.0068733923173962,0.0419975920410397,0,0,18.64719736222327,92.8648611058008,B2M;ICAM1
118,BioPlanet_2019,Neurotrophin signaling pathway,5 of 126,0.0079047442006308,0.0470884546192592,0,0,4.280991735537191,20.72125076892505,NFKBIA;MAPK14;CALM2;YWHAZ;YWHAH
119,BioPlanet_2019,Adhesion and diapedesis of lymphocytes,2 of 14,0.0079678106290563,0.0470884546192592,0,0,17.092400690846286,82.59638599702767,CXCL8;ICAM1
120,BioPlanet_2019,Sema3A-plexin repulsion signaling by inhibiting integrin adhesion,2 of 14,0.0079678106290563,0.0470884546192592,0,0,17.092400690846286,82.59638599702767,RRAS;RND1
121,BioPlanet_2019,Interleukin-6 regulation of target genes,2 of 14,0.0079678106290563,0.0470884546192592,0,0,17.092400690846286,82.59638599702767,TIMP1;ICAM1
122,BioPlanet_2019,Beta-3 integrin cell surface interactions,3 of 43,0.0084582912374738,0.0493316468177359,0,0,7.720703125,36.84789032728152,SPP1;ITGAV;EDIL3
123,BioPlanet_2019,Platelet homeostasis,4 of 82,0.0084842221988893,0.0493316468177359,0,0,5.296549872466103,25.26214383146082,GNG10;PPP2R1B;GNG5;MAPK14
721,Panther_2016,Interferon-gamma signaling pathway Homo sapiens P00035,5 of 28,6.854614297175697e-06,0.00022750785655843456,0,0,22.633867276887877,269.1300022347592,SOCS2;SOCS3;IFNGR2;MAPK14;JAK1
722,Panther_2016,JAK/STAT signaling pathway Homo sapiens P00038,4 of 14,8.125280591372663e-06,0.00022750785655843456,0,0,41.45549738219896,485.8804130047228,STAT5B;SOCS1;STAT3;JAK1
723,Panther_2016,CCKR signaling map ST Homo sapiens P06959,8 of 165,0.0002201631352175614,0.0031084835686361,0,0,5.353860826322422,45.08562099616625,NFKBIA;CHGA;CXCL8;STAT3;ITGAV;MAPK14;IER3;BIRC3
724,Panther_2016,TGF-beta signaling pathway Homo sapiens P00052,6 of 88,0.0002220345406168702,0.0031084835686361,0,0,7.635694928377855,64.23663968310242,RRAS;INHBA;MAPK14;JUNB;SKIL;BMP5
725,Panther_2016,Inflammation mediated by chemokine and cytokine signaling pathway Homo sapiens P00031,8 of 188,0.0005285335997309312,0.0059195763169864,0,0,4.664289958407606,35.193952944353114,GNG10;CXCL8;RRAS;GNG5;ARPC1B;STAT3;JUNB;NFKB2
726,Panther_2016,EGF receptor signaling pathway Homo sapiens P00018,6 of 109,0.0007009333856991345,0.0065420449331919,0,0,6.072430266605024,44.104654320875575,STAT5B;RRAS;STAT3;MAPK14;YWHAZ;YWHAH
727,Panther_2016,Cortocotropin releasing factor receptor signaling pathway Homo sapiens P04380,3 of 30,0.0030523947920427,0.0244191583363419,0,0,11.445601851851851,66.29096665331821,VAMP8;GNG10;GNG5
728,Panther_2016,Integrin signalling pathway Homo sapiens P00034,6 of 156,0.00431939766627,0.0302357836638901,0,0,4.15978835978836,22.648547248076863,RRAS;ACTN1;ARPC1B;ITGA1;ITGAV;RND1
777,KEGG_2019_Human,Human cytomegalovirus infection,14 of 225,4.709947436378172e-08,1.0314784885668196e-05,0,0,7.18273938886125,121.18002493163972,CXCL8;STAT3;MAPK14;TMEM173;HLA-E;TAPBP;NFKBIA;GNG10;GNG5;ITGAV;CALR;CALM2;B2M;JAK1
778,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,12 of 186,2.98543304432712e-07,3.2690491835381965e-05,0,0,7.398153382325231,111.15245199276488,NFKBIA;ZFP36;GNG10;CXCL8;GNG5;STAT3;MAPK14;HIF1A;CALM2;ICAM1;HLA-E;JAK1
779,KEGG_2019_Human,Antigen processing and presentation,8 of 77,8.372669944086569e-07,6.112049059183195e-05,0,0,12.23653413934744,171.22732519586,PSME1;PSME2;CALR;IFI30;B2M;CTSS;TAPBP;HLA-E
780,KEGG_2019_Human,Epstein-Barr virus infection,11 of 201,4.682824249754327e-06,0.0001957867040483523,0,0,6.171767734553776,75.73752145166519,NFKBIA;GADD45B;STAT3;CALR;MAPK14;B2M;HLA-E;ICAM1;JAK1;NFKB2;TAPBP
781,KEGG_2019_Human,Pathways in cancer,18 of 530,4.724455262704139e-06,0.0001957867040483523,0,0,3.83203125,46.991272986069205,STAT5B;CXCL8;GADD45B;EPAS1;IFNGR2;STAT3;HIF1A;HSP90B1;NFKB2;NFKBIA;GNG10;GNG5;ITGAV;CALM2;JAK1;BIRC3;IL13RA1;NFE2L2
782,KEGG_2019_Human,Prolactin signaling pathway,7 of 70,5.3640192889959535e-06,0.0001957867040483523,0,0,11.667848699763594,141.59864320669308,SOCS2;SOCS3;STAT5B;SOCS1;IRF1;STAT3;MAPK14
783,KEGG_2019_Human,Toxoplasmosis,8 of 113,1.5102445401529404e-05,0.0004724907918478485,0,0,8.026483320600967,89.09921321666205,NFKBIA;SOCS1;IFNGR2;STAT3;MAPK14;LDLR;JAK1;BIRC3
784,KEGG_2019_Human,Osteoclast differentiation,8 of 127,3.5226253852812534e-05,0.0009643186992207432,0,0,7.077158135981666,72.56719017453896,NFKBIA;SOCS3;SOCS1;IFNGR2;MAPK14;JUNB;NFKB2;JAK1
785,KEGG_2019_Human,Human immunodeficiency virus 1 infection,10 of 212,4.574030750992685e-05,0.0011130141494082,0,0,5.245651592186245,52.41733429522798,NFKBIA;GNG10;GNG5;CALR;MAPK14;TMEM173;CALM2;B2M;HLA-E;TAPBP
786,KEGG_2019_Human,Th17 cell differentiation,7 of 107,8.615627395686847e-05,0.0018868223996554,0,0,7.336968085106383,68.6692358982072,NFKBIA;STAT5B;IFNGR2;STAT3;MAPK14;HIF1A;JAK1
787,KEGG_2019_Human,TNF signaling pathway,7 of 110,0.00010259238143390745,0.0020425210485477,0,0,7.122185498863871,65.41547106094308,NFKBIA;SOCS3;IRF1;MAPK14;JUNB;ICAM1;BIRC3
788,KEGG_2019_Human,Hepatitis C,8 of 155,0.0001433749317153422,0.0026165925038049,0,0,5.7209793008112335,50.63093832288311,NFKBIA;SOCS3;PPP2R1B;STAT3;YWHAZ;LDLR;YWHAH;JAK1
789,KEGG_2019_Human,Viral carcinogenesis,9 of 201,0.00016315646850670687,0.0027485589694591,0,0,4.942792338709677,43.10510781714383,NFKBIA;STAT5B;ACTN1;STAT3;YWHAZ;HLA-E;JAK1;NFKB2;YWHAH
790,KEGG_2019_Human,JAK-STAT signaling pathway,8 of 162,0.0001942399077401041,0.0030384671282202,0,0,5.45899020765331,46.65480412089516,SOCS2;SOCS3;STAT5B;SOCS1;IFNGR2;STAT3;IL13RA1;JAK1
791,KEGG_2019_Human,IL-17 signaling pathway,6 of 93,0.0002999948267193732,0.0042238624845857,0,0,7.195037401933954,58.36431102794807,NFKBIA;CXCL8;LCN2;MAPK14;IL17RB;HSP90B1
792,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,9 of 219,0.0003085926929377738,0.0042238624845857,0,0,4.514976958525345,36.49676340283376,NFKBIA;STAT5B;ZFP36;CALR;B2M;HLA-E;ICAM1;JAK1;NFKB2
793,KEGG_2019_Human,NF-kappa B signaling pathway,6 of 95,0.000336599403160124,0.004336192311298,0,0,7.032637774210808,56.23731112717083,NFKBIA;CXCL8;GADD45B;ICAM1;BIRC3;NFKB2
794,KEGG_2019_Human,NOD-like receptor signaling pathway,8 of 178,0.00036746330935792784,0.0044708035971881,0,0,4.941176470588236,39.07920676195894,NFKBIA;CXCL8;NAMPT;CASP4;TMEM173;MAPK14;JAK1;BIRC3
795,KEGG_2019_Human,Insulin signaling pathway,7 of 137,0.000397754477815543,0.0045846437179791,0,0,5.635229132569558,44.12201622534393,SOCS2;SOCS3;PTPN1;SOCS1;FLOT1;CALM2;RHOQ
796,KEGG_2019_Human,Chagas disease (American trypanosomiasis),6 of 103,0.0005193166742358497,0.0056865175828825,0,0,6.450008181966945,48.78139058594986,NFKBIA;CXCL8;PPP2R1B;IFNGR2;CALR;MAPK14
797,KEGG_2019_Human,C-type lectin receptor signaling pathway,6 of 104,0.0005467076318976923,0.0057013795897902,0,0,6.383867832847424,47.95303858164846,NFKBIA;RRAS;IRF1;MAPK14;CALM2;NFKB2
798,KEGG_2019_Human,Ferroptosis,4 of 40,0.0006085036001905593,0.0060573767473514,0,0,11.500290866783011,85.15399260946035,MAP1LC3B;FTH1;SLC39A14;CP
799,KEGG_2019_Human,PI3K-Akt signaling pathway,11 of 354,0.0007379177075620386,0.0070262599111341,0,0,3.3920965901888707,24.462709191017403,GNG10;GNG5;PPP2R1B;ITGA1;SPP1;ITGAV;EFNA5;YWHAZ;JAK1;HSP90B1;YWHAH
800,KEGG_2019_Human,Necroptosis,7 of 162,0.0010749459847701,0.0097594326246904,0,0,4.720315717227179,32.26564664497063,STAT5B;FTH1;IFNGR2;STAT3;GLUL;JAK1;BIRC3
801,KEGG_2019_Human,Hepatitis B,7 of 163,0.0011140904822705,0.0097594326246904,0,0,4.689818603382433,31.88943889935492,NFKBIA;STAT5B;CXCL8;STAT3;MAPK14;YWHAZ;JAK1
802,KEGG_2019_Human,Influenza A,7 of 171,0.0014690969478882,0.0123743165995206,0,0,4.459230669434354,29.088040525156327,NFKBIA;SOCS3;CXCL8;IFNGR2;MAPK14;ICAM1;JAK1
803,KEGG_2019_Human,Dopaminergic synapse,6 of 131,0.0018140604830817,0.0147140461405519,0,0,4.998095238095238,31.54891471286449,GNG10;PPP2R1B;GNG5;KIF5B;MAPK14;CALM2
804,KEGG_2019_Human,Th1 and Th2 cell differentiation,5 of 92,0.0020735835261549,0.016218385436712,0,0,5.964307320024198,36.850335576232574,NFKBIA;STAT5B;IFNGR2;MAPK14;JAK1
805,KEGG_2019_Human,Transcriptional misregulation in cancer,7 of 186,0.0023672776553081,0.0172745673705764,0,0,4.082431950552716,24.682443391720646,CXCL8;GADD45B;H3F3B;BCL6;LMO2;H3F3A;BIRC3
806,KEGG_2019_Human,Fluid shear stress and atherosclerosis,6 of 139,0.0024452583949217,0.0172745673705764,0,0,4.695548394796515,28.237170856641555,ITGAV;MAPK14;CALM2;ICAM1;HSP90B1;NFE2L2
807,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,6 of 139,0.0024452583949217,0.0172745673705764,0,0,4.695548394796515,28.237170856641555,ID1;STAT3;INHBA;MAPK14;SKIL;JAK1
808,KEGG_2019_Human,Circadian entrainment,5 of 97,0.002613403179601,0.017885478010395,0,0,5.6387299771167045,33.53410236247111,ADCYAP1;GNG10;RASD1;GNG5;CALM2
809,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,5 of 100,0.002982454018199,0.019792649393503,0,0,5.45983379501385,31.748981680901213,STAT5B;CXCL8;STAT3;MAPK14;ICAM1
810,KEGG_2019_Human,Shigellosis,4 of 65,0.0037314448536958,0.0240348947929232,0,0,6.778473950733843,37.89817509337696,NFKBIA;CXCL8;ARPC1B;MAPK14
811,KEGG_2019_Human,RIG-I-like receptor signaling pathway,4 of 70,0.0048667585902412,0.0288999884617087,0,0,6.263366650801205,33.35447648035449,NFKBIA;CXCL8;TMEM173;MAPK14
812,KEGG_2019_Human,Cellular senescence,6 of 160,0.0048826464524348,0.0288999884617087,0,0,4.050917336631622,21.55925712399492,CXCL8;RRAS;GADD45B;MAPK14;CALM2;HLA-E
813,KEGG_2019_Human,Hippo signaling pathway,6 of 160,0.0048826464524348,0.0288999884617087,0,0,4.050917336631622,21.55925712399492,PPP2R1B;WWC1;ID1;YWHAZ;BMP5;YWHAH
814,KEGG_2019_Human,Leishmaniasis,4 of 74,0.0059265169910196,0.0341554531850867,0,0,5.904263275991025,30.27894313323253,NFKBIA;IFNGR2;MAPK14;JAK1
815,KEGG_2019_Human,Pertussis,4 of 76,0.0065097236505435,0.0365546020376677,0,0,5.739674229203025,28.896150411301253,CXCL8;IRF1;MAPK14;CALM2
996,Reactome_2022,Cytokine Signaling In Immune System R-HSA-1280215,33 of 702,5.378750240126964e-14,3.840427671450652e-11,0,0,5.826717599512817,178.02798692427982,CXCL8;CEBPD;IFI30;HIF1A;ICAM1;HSP90B1;SOCS2;SOCS3;MT2A;SOCS1;PPP2R1B;TIMP1;B2M;JAK1;IL13RA1;STAT5B;PTPN1;ANXA2;TNFRSF12A;IFNGR2;STAT3;MAPK14;YWHAZ;IL17RB;HLA-E;NFKB2;NFKBIA;BCL6;IRF1;PSME1;LCN2;PSME2;BIRC3
997,Reactome_2022,Signaling By Interleukins R-HSA-449147,24 of 453,1.7250120208147758e-11,6.158292914308751e-09,0,0,6.33901770743876,157.1011563496726,STAT5B;CXCL8;ANXA2;CEBPD;STAT3;MAPK14;HIF1A;YWHAZ;IL17RB;ICAM1;HSP90B1;NFKB2;SOCS2;NFKBIA;SOCS3;SOCS1;BCL6;PPP2R1B;PSME1;LCN2;PSME2;TIMP1;JAK1;IL13RA1
998,Reactome_2022,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,13 of 107,3.912227386641975e-11,9.3111011802079e-09,0,0,14.977963525835866,358.93684788536194,CXCL8;CEBPD;STAT3;HIF1A;ICAM1;HSP90B1;SOCS3;SOCS1;BCL6;LCN2;TIMP1;IL13RA1;JAK1
999,Reactome_2022,Immune System R-HSA-168256,50 of 1943,9.964124194894243e-11,1.7785961687886225e-08,0,0,3.2628376778330326,75.14134071915225,CXCL8;ARPC1B;IFI30;CTSS;ICAM1;MT2A;PPP2R1B;FTH1;KIF5B;CASP4;ITGAV;TIMP1;B2M;JAK1;IL13RA1;SERPINB1;ANXA2;TNFRSF12A;IFNGR2;YWHAZ;IL17RB;HLA-E;TAPBP;VAMP8;IRF1;PSME1;PSME2;CFB;BIRC3;CEBPD;HIF1A;AGPAT2;HSP90B1;SOCS2;SOCS3;SDCBP;SOCS1;S100A11;CHGA;STAT5B;PTPN1;STAT3;RAB27A;MAPK14;NFKB2;NFKBIA;KLHL5;BCL6;LCN2;CALR
1000,Reactome_2022,Interferon Gamma Signaling R-HSA-877300,11 of 89,1.074114180394794e-09,1.5338350496037664e-07,0,0,15.119634894091416,312.24721526032346,SOCS3;PTPN1;MT2A;SOCS1;IFNGR2;IRF1;IFI30;B2M;ICAM1;JAK1;HLA-E
1001,Reactome_2022,Growth Hormone Receptor Signaling R-HSA-982772,6 of 24,9.24862053672645e-08,1.1005858438704477e-05,0,0,34.89770723104056,565.2104669223701,SOCS2;PTPN1;STAT5B;SOCS3;SOCS1;STAT3
1002,Reactome_2022,Regulation Of IFNG Signaling R-HSA-877312,5 of 14,1.5601160529384307e-07,1.591318373997199e-05,0,0,57.88304093567251,907.220316846268,PTPN1;SOCS3;SOCS1;IFNGR2;JAK1
1003,Reactome_2022,Antigen processing-Cross Presentation R-HSA-1236975,9 of 104,8.186992055425481e-07,7.306890409467242e-05,0,0,10.03904923599321,140.70278739356158,VAMP8;PSME1;PSME2;ITGAV;CALR;B2M;CTSS;HLA-E;TAPBP
1004,Reactome_2022,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,5 of 25,3.794648346672757e-06,0.0002709378919524349,0,0,26.032894736842103,324.9404785904294,SOCS3;STAT5B;SOCS1;STAT3;JAK1
1005,Reactome_2022,Interleukin-7 Signaling R-HSA-1266695,5 of 25,3.794648346672757e-06,0.0002709378919524349,0,0,26.032894736842103,324.9404785904294,SOCS2;STAT5B;SOCS1;STAT3;JAK1
1006,Reactome_2022,Interferon Signaling R-HSA-913531,11 of 200,4.46406332912381e-06,0.0002897582924540364,0,0,6.2047389003910745,76.43897775925142,SOCS3;PTPN1;MT2A;SOCS1;IFNGR2;IRF1;IFI30;B2M;HLA-E;ICAM1;JAK1
1007,Reactome_2022,Innate Immune System R-HSA-168249,26 of 1035,9.14746069906502e-06,0.0005373201096026709,0,0,2.8658992147594726,33.25026080776945,ARPC1B;AGPAT2;CTSS;HSP90B1;SDCBP;SOCS1;PPP2R1B;FTH1;CASP4;ITGAV;B2M;S100A11;CHGA;SERPINB1;ANXA2;RAB27A;MAPK14;HLA-E;NFKB2;VAMP8;NFKBIA;PSME1;LCN2;PSME2;CFB;BIRC3
1008,Reactome_2022,Signaling By CSF3 (G-CSF) R-HSA-9674555,5 of 30,9.7831392504688e-06,0.0005373201096026709,0,0,20.821052631578947,240.16772183456703,SOCS3;STAT5B;SOCS1;STAT3;JAK1
1009,Reactome_2022,ER-Phagosome Pathway R-HSA-1236974,7 of 89,2.638103435048465e-05,0.0013454327518747,0,0,8.955695381421899,94.4186891946862,VAMP8;PSME1;PSME2;CALR;B2M;HLA-E;TAPBP
1010,Reactome_2022,Programmed Cell Death R-HSA-5357801,10 of 208,3.893296442748359e-05,0.0018532091067482,0,0,5.352716352716353,54.34971144313732,SDCBP;IRF1;STAT3;CASP4;PSME1;FLOT1;PSME2;YWHAZ;BIRC3;YWHAH
1011,Reactome_2022,Signal Transduction R-HSA-162582,44 of 2465,4.468146218569559e-05,0.0019939102500366,0,0,2.092332269244552,20.95669928087963,CXCL8;EPAS1;ARPC1B;WWC1;SPPL2A;RHOBTB3;ARHGEF10L;HIF1A;RND1;SOCS3;GNG10;SOCS1;GNG5;PPP2R1B;KIF5B;RDH10;PEA15;FLOT1;ITGAV;SKIL;TMED5;IER3;JAK1;YWHAH;CHGA;STAT5B;PTPN1;ACTN1;STAT3;INHBA;MAPK14;YWHAZ;NFKBIA;ADCYAP1;ELF3;VGF;ID1;PSME1;PSME2;TAX1BP3;RHOQ;CDK5R2;CDC42SE2;BIRC3
1012,Reactome_2022,Interferon Alpha/Beta Signaling R-HSA-909733,6 of 72,7.281457676850712e-05,0.0027997059490606,0,0,9.494468494468494,90.45944478736608,SOCS3;PTPN1;SOCS1;IRF1;JAK1;HLA-E
1013,Reactome_2022,Interleukin-9 Signaling R-HSA-8985947,3 of 9,7.34205724789232e-05,0.0027997059490606,0,0,51.559895833333336,490.8144454929683,STAT5B;STAT3;JAK1
1014,Reactome_2022,Interleukin-10 Signaling R-HSA-6783783,5 of 45,7.450197903662802e-05,0.0027997059490606,0,0,13.00328947368421,123.59216870361232,CXCL8;STAT3;TIMP1;ICAM1;JAK1
1015,Reactome_2022,Regulation Of IFNA/IFNB Signaling R-HSA-912694,4 of 25,9.44095967986292e-05,0.003370422605711,0,0,19.729743206182995,182.8526523345712,SOCS3;PTPN1;SOCS1;JAK1
1016,Reactome_2022,Interleukin-21 Signaling R-HSA-9020958,3 of 10,0.00010413357255158714,0.0034707621180051,0,0,44.191964285714285,405.2330708264109,STAT5B;STAT3;JAK1
1017,Reactome_2022,Interleukin-20 Family Signaling R-HSA-8854691,4 of 26,0.00011072763243715492,0.0034707621180051,0,0,18.831984769157543,171.52994937618263,SOCS3;STAT5B;STAT3;JAK1
1018,Reactome_2022,Cellular Responses To Stimuli R-HSA-8953897,19 of 736,0.00011180326150436784,0.0034707621180051,0,0,2.8739698237606186,26.149589910393757,GPX2;CXCL8;SMARCD3;EPAS1;STAT3;MAPK14;HIF1A;HSP90B1;MT2A;MAP1LC3B;SESN1;ID1;PSME1;PSME2;HDGF;CALR;FNIP2;ATF3;NFE2L2
1019,Reactome_2022,Signaling By NTRK1 (TRKA) R-HSA-187037,7 of 114,0.0001283880883762424,0.0036924802534052,0,0,6.85454364684828,61.41981577733346,ADCYAP1;PPP2R1B;VGF;ID1;STAT3;MAPK14;CDK5R2
1020,Reactome_2022,Endosomal/Vacuolar Pathway R-HSA-1236977,3 of 11,0.0001421561766692847,0.0036924802534052,0,0,38.666015625,342.52615776208006,B2M;CTSS;HLA-E
1021,Reactome_2022,Signaling By Leptin R-HSA-2586552,3 of 11,0.0001421561766692847,0.0036924802534052,0,0,38.666015625,342.52615776208006,SOCS3;STAT5B;STAT3
1022,Reactome_2022,Interleukin-6 Signaling R-HSA-1059683,3 of 11,0.0001421561766692847,0.0036924802534052,0,0,38.666015625,342.52615776208006,SOCS3;STAT3;JAK1
1023,Reactome_2022,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",4 of 28,0.0001493550696201232,0.0036924802534052,0,0,17.260907504363,152.05451140940045,CALR;B2M;HLA-E;TAPBP
1024,Reactome_2022,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,5 of 52,0.0001499746881635189,0.0036924802534052,0,0,11.062709966405375,97.4076482754437,SOCS3;PTPN1;EPAS1;STAT3;HIF1A
1025,Reactome_2022,Hemostasis R-HSA-109582,16 of 576,0.0001743534463232357,0.004149612022493,0,0,3.0718276137270557,26.58490482410449,PTPN1;ANXA2;ACTN1;ITGA1;MAPK14;ATP1B1;YWHAZ;SLC7A5;GNG10;GNG5;PPP2R1B;TMSB4X;KIF5B;IRF1;ITGAV;TIMP1
1026,Reactome_2022,Toll-like Receptor Cascades R-HSA-168898,8 of 162,0.0001942399077401041,0.0044737836814978,0,0,5.45899020765331,46.65480412089516,NFKBIA;SOCS1;PPP2R1B;MAPK14;CTSS;HSP90B1;NFKB2;BIRC3
1027,Reactome_2022,Regulated Necrosis R-HSA-5218859,5 of 57,0.00023229304136623317,0.005183038485484,0,0,9.996457489878544,83.64546674815988,SDCBP;IRF1;CASP4;FLOT1;BIRC3
1028,Reactome_2022,Cellular Responses To Stress R-HSA-2262752,18 of 722,0.0002604009152973233,0.0056341288946148,0,0,2.759196841294299,22.772446545953013,GPX2;CXCL8;SMARCD3;EPAS1;STAT3;MAPK14;HIF1A;HSP90B1;MAP1LC3B;SESN1;ID1;PSME1;PSME2;HDGF;CALR;FNIP2;ATF3;NFE2L2
1029,Reactome_2022,Interleukin-15 Signaling R-HSA-8983432,3 of 14,0.00030690765289973323,0.0061717636211982,0,0,28.116477272727277,227.43316292078129,STAT5B;STAT3;JAK1
1030,Reactome_2022,Adaptive Immune System R-HSA-1280218,18 of 733,0.00031231481551293166,0.0061717636211982,0,0,2.715183121962783,21.9155974594881,IFI30;YWHAZ;CTSS;HLA-E;ICAM1;TAPBP;VAMP8;NFKBIA;SOCS3;SOCS1;KLHL5;PPP2R1B;KIF5B;PSME1;PSME2;ITGAV;CALR;B2M
1031,Reactome_2022,Signaling By NTRKs R-HSA-166520,7 of 132,0.0003174603914577977,0.0061717636211982,0,0,5.862127659574468,47.22036157552001,ADCYAP1;PPP2R1B;VGF;ID1;STAT3;MAPK14;CDK5R2
1032,Reactome_2022,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,5 of 61,0.0003198252856923476,0.0061717636211982,0,0,9.280545112781954,74.68737415912827,PPP2R1B;VGF;ID1;MAPK14;CDK5R2
1033,Reactome_2022,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,12 of 378,0.00035206981056177514,0.0066152064405554,0,0,3.4827555316671144,27.693761255478567,VAMP8;SOCS3;SOCS1;KLHL5;PSME1;PSME2;ITGAV;CALR;B2M;CTSS;HLA-E;TAPBP
1034,Reactome_2022,Cellular Response To Chemical Stress R-HSA-9711123,8 of 182,0.0004262391693821575,0.0078034555625348,0,0,4.826602741410044,37.45689854517571,MAP1LC3B;GPX2;SMARCD3;SESN1;STAT3;PSME1;PSME2;NFE2L2
1035,Reactome_2022,Post-translational Protein Phosphorylation R-HSA-8957275,6 of 106,0.0006048504164296241,0.0107965799332687,0,0,6.255555555555556,46.356978208110654,VGF;IGFBP4;VWA1;TIMP1;CP;HSP90B1
1036,Reactome_2022,Neutrophil Degranulation R-HSA-6798695,13 of 468,0.000710371131534518,0.0123708533637962,0,0,3.0376766091051803,22.022313991829165,SERPINB1;ANXA2;RAB27A;MAPK14;AGPAT2;CTSS;VAMP8;SDCBP;FTH1;LCN2;ITGAV;B2M;S100A11
1037,Reactome_2022,Scavenging By Class A Receptors R-HSA-3000480,3 of 19,0.0007881908538629312,0.0133992445156698,0,0,19.3251953125,138.09340664968948,FTH1;CALR;HSP90B1
1038,Reactome_2022,PTK6 Expression R-HSA-8849473,2 of 5,0.0009276507005693904,0.0154033162838731,0,0,68.40069084628671,477.63212634540446,EPAS1;HIF1A
1039,Reactome_2022,Infectious Disease R-HSA-5663205,20 of 961,0.0011715907984926,0.0190117234119032,0,0,2.291058144830727,15.463251339856424,CHGA;CEBPD;ARPC1B;IFNGR2;MAPK14;ATP1B1;YWHAZ;HLA-E;NFKB2;ADCYAP1;GNG10;MAP1LC3B;GNG5;PSME1;PSME2;CALR;B2M;JAK1;NFE2L2;YWHAH
1040,Reactome_2022,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,6 of 123,0.0013148971226515,0.0208630343460708,0,0,5.342016008682675,35.438917374987106,VGF;IGFBP4;VWA1;TIMP1;CP;HSP90B1
1041,Reactome_2022,Disease R-HSA-1643685,30 of 1736,0.0014900028002591,0.0231274347692404,0,0,1.9289139933923047,12.555257357404807,CEBPD;ARPC1B;PAPSS2;GNG10;MAP1LC3B;GNG5;PPP2R1B;KIF5B;RBBP8;IDS;B2M;JAK1;YWHAH;CHGA;STAT5B;IFNGR2;STAT3;MAPK14;ATP1B1;CP;YWHAZ;HLA-E;NFKB2;NFKBIA;ADCYAP1;RBP1;PSME1;PSME2;CALR;NFE2L2
1042,Reactome_2022,Interleukin-6 Family Signaling R-HSA-6783589,3 of 24,0.0015883799229293,0.0241298567015231,0,0,14.720238095238097,94.87253361681506,SOCS3;STAT3;JAK1
1043,Reactome_2022,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,5 of 88,0.0017043078972798,0.0250894579631432,0,0,6.253012048192771,39.86042669092719,ZFP36;PSME1;PSME2;MAPK14;YWHAZ
1044,Reactome_2022,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",4 of 53,0.0017668503426965,0.0250894579631432,0,0,8.443637140720162,53.520473487818656,CASP4;MAPK14;BIRC3;NFKB2
1045,Reactome_2022,Unfolded Protein Response (UPR) R-HSA-381119,5 of 89,0.0017916968985497,0.0250894579631432,0,0,6.178258145363409,39.07496278253976,CXCL8;HDGF;CALR;ATF3;HSP90B1
1046,Reactome_2022,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,3 of 25,0.0017921041402245,0.0250894579631432,0,0,14.050426136363637,88.86002121459535,GNG10;GNG5;MAPK14
1047,Reactome_2022,Interleukin-12 Family Signaling R-HSA-447115,4 of 54,0.0018938274768465,0.0259081696344502,0,0,8.27434554973822,51.87315789990157,ANXA2;STAT3;PSME2;JAK1
1048,Reactome_2022,IkBA Variant Leads To EDA-ID R-HSA-5603029,2 of 7,0.0019231554490558,0.0259081696344502,0,0,41.03626943005181,256.63212846056393,NFKBIA;NFKB2
1049,Reactome_2022,Neddylation R-HSA-8951664,8 of 237,0.0023263697346804,0.0307597776029974,0,0,3.6571001564579775,22.174630340058854,SOCS2;SOCS3;KLHL5;EPAS1;PSME1;PSME2;HIF1A;NFE2L2
1050,Reactome_2022,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,6 of 140,0.0025344538645605,0.0324841580719212,0,0,4.660270078180526,27.85805576803964,NFKBIA;SOCS1;PPP2R1B;MAPK14;NFKB2;BIRC3
1051,Reactome_2022,Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,2 of 8,0.00254777710368,0.0324841580719212,0,0,34.19516407599309,204.2317809011976,RRAS;RND1
1052,Reactome_2022,Regulation Of Necroptotic Cell Death R-HSA-5675482,3 of 29,0.0027668426558877,0.0346583448474354,0,0,11.88641826923077,70.01157943508804,SDCBP;FLOT1;BIRC3
1053,Reactome_2022,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,5 of 100,0.002982454018199,0.0360927486270195,0,0,5.45983379501385,31.748981680901213,TNFRSF12A;PSME1;PSME2;NFKB2;BIRC3
1054,Reactome_2022,KEAP1-NFE2L2 Pathway R-HSA-9755511,5 of 100,0.002982454018199,0.0360927486270195,0,0,5.45983379501385,31.748981680901213,MAP1LC3B;SESN1;PSME1;PSME2;NFE2L2
1055,Reactome_2022,Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,3 of 30,0.0030523947920427,0.0363234980253087,0,0,11.445601851851851,66.29096665331821,TSC22D1;EPAS1;STAT3
1056,Reactome_2022,ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,2 of 9,0.0032547398103224,0.0380964626978729,0,0,29.308660251665437,167.8695410270378,CALR;HSP90B1
1057,Reactome_2022,RIPK1-mediated Regulated Necrosis R-HSA-5213460,3 of 31,0.003355402117059,0.0383944700765578,0,0,11.036272321428571,62.875670333502086,SDCBP;FLOT1;BIRC3
1058,Reactome_2022,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,5 of 103,0.0033877473596962,0.0383944700765578,0,0,5.291890440386681,30.098103542125084,NFKBIA;PPP2R1B;MAPK14;NFKB2;BIRC3
1059,Reactome_2022,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,4 of 64,0.0035282973254432,0.0384218696474661,0,0,6.891797556719022,38.917566388456045,EPAS1;PSME1;PSME2;HIF1A
1060,Reactome_2022,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,12 of 496,0.0035468271771196,0.0384218696474661,0,0,2.61766698279366,14.768096602063933,STAT5B;PTPN1;ADCYAP1;SOCS1;VGF;PPP2R1B;ID1;STAT3;ITGAV;MAPK14;HIF1A;CDK5R2
1061,Reactome_2022,"Platelet Activation, Signaling And Aggregation R-HSA-76002",8 of 254,0.0035516013959842,0.0384218696474661,0,0,3.401417329681318,19.185206956079742,PTPN1;GNG10;GNG5;ACTN1;TMSB4X;TIMP1;MAPK14;YWHAZ
1062,Reactome_2022,Transport Of Small Molecules R-HSA-382551,15 of 706,0.0039838501697464,0.0390036510291838,0,0,2.3051133622768933,12.736918977056469,SLC43A2;ATP1B1;CP;SLC39A14;SLC7A2;SLC9B2;SLC7A5;SLC4A8;GNG10;GNG5;FTH1;PSME1;LCN2;PSME2;LDLR
1063,Reactome_2022,MyD88-independent TLR4 Cascade R-HSA-166166,5 of 107,0.0039878699014353,0.0390036510291838,0,0,5.083333333333333,28.08286508711035,NFKBIA;PPP2R1B;MAPK14;NFKB2;BIRC3
1064,Reactome_2022,Amino Acid Transport Across Plasma Membrane R-HSA-352230,3 of 33,0.0040150785017677,0.0390036510291838,0,0,10.299479166666666,56.82941950918719,SLC7A5;SLC43A2;SLC7A2
1065,Reactome_2022,Signal Amplification R-HSA-392518,3 of 33,0.0040150785017677,0.0390036510291838,0,0,10.299479166666666,56.82941950918719,GNG10;GNG5;MAPK14
1066,Reactome_2022,Glucagon-type Ligand Receptors R-HSA-420092,3 of 33,0.0040150785017677,0.0390036510291838,0,0,10.299479166666666,56.82941950918719,ADCYAP1;GNG10;GNG5
1067,Reactome_2022,NOD1/2 Signaling Pathway R-HSA-168638,3 of 33,0.0040150785017677,0.0390036510291838,0,0,10.299479166666666,56.82941950918719,CASP4;MAPK14;BIRC3
1068,Reactome_2022,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,2 of 10,0.0040423952047053,0.0390036510291838,0,0,25.64378238341969,141.32077911012436,STAT3;HIF1A
1069,Reactome_2022,Glycoprotein Hormones R-HSA-209822,2 of 10,0.0040423952047053,0.0390036510291838,0,0,25.64378238341969,141.32077911012436,CHGA;INHBA
1070,Reactome_2022,Post-translational Protein Modification R-HSA-597592,24 of 1383,0.004301073098124,0.0409462158941407,0,0,1.905012715748164,10.380206126826891,CHGA;RAB3B;EPAS1;IGFBP4;RAB27A;HIF1A;CP;HSP90B1;NFKB2;SOCS2;NFKBIA;SOCS3;KLHL5;TNIP1;VGF;PSME1;PSME2;VWA1;GCNT3;CALR;TIMP1;TOP1;BIRC3;NFE2L2
1071,Reactome_2022,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,5 of 112,0.0048404568881379,0.0432729743598539,0,0,4.844564682734875,25.82514460035314,NFKBIA;SOCS1;PPP2R1B;MAPK14;NFKB2
1072,Reactome_2022,ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,2 of 11,0.0049091189399834,0.0432729743598539,0,0,22.79332181922856,121.18436050948772,CALR;HSP90B1
1073,Reactome_2022,Pexophagy R-HSA-9664873,2 of 11,0.0049091189399834,0.0432729743598539,0,0,22.79332181922856,121.18436050948772,MAP1LC3B;EPAS1
1074,Reactome_2022,Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,2 of 11,0.0049091189399834,0.0432729743598539,0,0,22.79332181922856,121.18436050948772,EPAS1;HIF1A
1075,Reactome_2022,SUMOylation Of Immune Response Proteins R-HSA-4755510,2 of 11,0.0049091189399834,0.0432729743598539,0,0,22.79332181922856,121.18436050948772,NFKBIA;NFKB2
1076,Reactome_2022,Interleukin-27 Signaling R-HSA-9020956,2 of 11,0.0049091189399834,0.0432729743598539,0,0,22.79332181922856,121.18436050948772,STAT3;JAK1
1077,Reactome_2022,RHO GTPase Effectors R-HSA-195258,8 of 269,0.0050033042036818,0.0435653561149856,0,0,3.203474911385662,16.97091046876373,PPP2R1B;ARPC1B;KIF5B;TAX1BP3;MAPK14;YWHAZ;RHOQ;YWHAH
1078,Reactome_2022,Metabolism Of Proteins R-HSA-392499,30 of 1890,0.0052485741115887,0.0451503845261975,0,0,1.7541544477028348,9.20895797957498,RAB3B;EPAS1;HIF1A;HSP90B1;SOCS2;SOCS3;GNG10;GNG5;KIF5B;GCNT3;TIMP1;B2M;CHGA;IGFBP4;STAT3;RAB27A;INHBA;CP;NFKB2;NFKBIA;KLHL5;TNIP1;VGF;PSME1;PSME2;VWA1;CALR;TOP1;BIRC3;NFE2L2
1079,Reactome_2022,"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",14 of 660,0.0054199975271169,0.0460699789804937,0,0,2.293980808374528,11.969211720605294,ACTN1;ARPC1B;RHOBTB3;ARHGEF10L;MAPK14;YWHAZ;RND1;PPP2R1B;KIF5B;FLOT1;TAX1BP3;RHOQ;CDC42SE2;YWHAH
1080,Reactome_2022,Cellular Response To Hypoxia R-HSA-1234174,4 of 73,0.0056484327387254,0.047446835005294,0,0,5.990135822141285,31.007202277073144,EPAS1;PSME1;PSME2;HIF1A
1081,Reactome_2022,Peptide Hormone Biosynthesis R-HSA-209952,2 of 12,0.0058533103841373,0.0474916319803867,0,0,20.51295336787565,105.45192195191358,CHGA;INHBA
1082,Reactome_2022,Interleukin-2 Signaling R-HSA-9020558,2 of 12,0.0058533103841373,0.0474916319803867,0,0,20.51295336787565,105.45192195191358,STAT5B;JAK1
1083,Reactome_2022,Interleukin-35 Signaling R-HSA-8984722,2 of 12,0.0058533103841373,0.0474916319803867,0,0,20.51295336787565,105.45192195191358,STAT3;JAK1
1710,GO_Biological_Process_2023,Regulation Of Erythrocyte Differentiation (GO:0045646),6 of 36,1.214324913271843e-06,0.0018695117682236,0,0,20.925925925925927,285.0387806787925,STAT5B;ZFP36;STAT3;INHBA;MAPK14;HIF1A
1711,GO_Biological_Process_2023,Cellular Response To Cytokine Stimulus (GO:0071345),14 of 308,2.1136368210555624e-06,0.0018695117682236,0,0,5.133122862404631,67.07503223111442,STAT5B;CXCL8;STAT3;CIB1;HIF1A;NFKBIA;MT2A;ZFP36;SOCS1;IRF1;ZC3H12A;JAK1;IL13RA1;NFE2L2
1712,GO_Biological_Process_2023,Positive Regulation Of Erythrocyte Differentiation (GO:0045648),5 of 26,4.661085052857128e-06,0.0021426418004205,0,0,24.791979949874687,304.35284862671267,STAT5B;STAT3;INHBA;MAPK14;HIF1A
1713,GO_Biological_Process_2023,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),25 of 938,5.010777466660919e-06,0.0021426418004205,0,0,3.042974035178146,37.13621008052109,EPAS1;HIF1A;PTMS;ZC3H12A;NAMPT;APBB2;JUNB;LMO1;STAT5B;ANXA2;STAT3;LMO2;INHBA;ELL2;NFKB2;BMP5;NFKBIA;ADCYAP1;PLSCR1;TNIP1;ELF3;IRF1;ATF3;RHOQ;NFE2L2
1714,GO_Biological_Process_2023,Regulation Of Cell Population Proliferation (GO:0042127),22 of 766,6.05608196840181e-06,0.0021426418004205,0,0,3.257986823295419,39.142911666484544,STAT5B;BTG2;BTG1;CXCL8;TSC22D1;STAT3;ITGA1;CIB1;INHBA;SOD2;BMP5;SLC9A3R1;SDCBP;BCL6;FTH1;IRF1;NAMPT;ITGAV;CALR;TIMP1;JUNB;S100A11
1715,GO_Biological_Process_2023,Regulation Of Innate Immune Response (GO:0045088),7 of 78,1.107004576401314e-05,0.0028501053883001,0,0,10.348966137249024,118.0948227743762,PTPN1;PLSCR1;IRF1;YWHAZ;HLA-E;BIRC3;NFE2L2
1716,GO_Biological_Process_2023,Regulation Of Transcription By RNA Polymerase II (GO:0006357),40 of 2028,1.12779749678357e-05,0.0028501053883001,0,0,2.3128448108002857,26.34945190738713,SMARCD3;CEBPD;EPAS1;WWC1;HIF1A;PTMS;SDCBP;ZFP36;ZC3H12A;NAMPT;RBBP8;APBB2;JUNB;FNIP2;LMO1;STAT5B;ANXA2;STAT3;LMO2;ARID5B;INHBA;MAPK14;SOD2;YWHAZ;HOPX;NFKB2;BMP5;NFKBIA;ADCYAP1;PLSCR1;TNIP1;ELF3;BCL6;IRF1;ID1;HDGF;CALR;ATF3;RHOQ;NFE2L2
1717,GO_Biological_Process_2023,Growth Hormone Receptor Signaling Pathway (GO:0060396),4 of 17,1.888087022596515e-05,0.0036384868736261,0,0,31.884011276681434,346.81391053569143,SOCS2;PTPN1;STAT5B;STAT3
1718,GO_Biological_Process_2023,Negative Regulation Of Cellular Process (GO:0048523),17 of 537,2.165792476442209e-05,0.0036384868736261,0,0,3.5419727744165947,38.04128039390729,BTG2;BTG1;CXCL8;ITGA1;CIB1;INHBA;SOD2;HOPX;BMP5;RND1;VAMP8;SLC9A3R1;BCL6;FTH1;IRF1;ANXA6;S100A11
1719,GO_Biological_Process_2023,Cellular Response To Tumor Necrosis Factor (GO:0071356),8 of 119,2.202291580161328e-05,0.0036384868736261,0,0,7.590306884424532,81.3941019298031,NFKBIA;ZFP36;CXCL8;TMSB4X;ZC3H12A;CIB1;NFE2L2;BIRC3
1720,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),4 of 18,2.409064435491527e-05,0.0036384868736261,0,0,29.605086013462977,314.8112180940024,CALR;IFI30;B2M;TAPBP
1721,GO_Biological_Process_2023,Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),5 of 36,2.468165205399329e-05,0.0036384868736261,0,0,16.786078098471986,178.0910633687268,STAT5B;STAT3;INHBA;MAPK14;HIF1A
1722,GO_Biological_Process_2023,T-helper 17 Cell Lineage Commitment (GO:0072540),3 of 7,3.103614991127606e-05,0.0039216392280748,0,0,77.34765625,802.89635511986,SOCS3;STAT3;JAK1
1723,GO_Biological_Process_2023,Growth Hormone Receptor Signaling Pathway Via JAK-STAT (GO:0060397),3 of 7,3.103614991127606e-05,0.0039216392280748,0,0,77.34765625,802.89635511986,PTPN1;STAT5B;STAT3
1724,GO_Biological_Process_2023,T-helper 17 Cell Differentiation (GO:0072539),3 of 8,4.930110236580527e-05,0.0058142433390073,0,0,61.875,613.6492797272757,SOCS3;STAT3;JAK1
1725,GO_Biological_Process_2023,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),13 of 364,6.216056775206806e-05,0.006872627772088,0,0,3.958892958892959,38.34500471680298,PTPN1;CXCL8;ANXA2;GCGR;STAT3;RAB27A;INHBA;MAPK14;HIF1A;NFKBIA;PLSCR1;ZC3H12A;NFE2L2
1726,GO_Biological_Process_2023,Type II Interferon-Mediated Signaling Pathway (GO:0060333),3 of 9,7.34205724789232e-05,0.0075952309249823,0,0,51.559895833333336,490.8144454929683,IFNGR2;IRF1;JAK1
1727,GO_Biological_Process_2023,Positive Regulation Of DNA-templated Transcription (GO:0045893),27 of 1243,7.728329940626437e-05,0.0075952309249823,0,0,2.456840343045113,23.261444644695715,SMARCD3;EPAS1;HIF1A;PTMS;ZC3H12A;NAMPT;SPP1;APBB2;JUNB;YWHAH;LMO1;STAT5B;ANXA2;STAT3;LMO2;INHBA;NFKB2;BMP5;NFKBIA;ADCYAP1;PLSCR1;TNIP1;ELF3;IRF1;ATF3;RHOQ;NFE2L2
1728,GO_Biological_Process_2023,Response To Tumor Necrosis Factor (GO:0034612),7 of 108,9.137700227296668e-05,0.0082568597609797,0,0,7.263956182852327,67.55854598596835,NFKBIA;ZFP36;CXCL8;GCH1;ZC3H12A;CIB1;NFE2L2
1729,GO_Biological_Process_2023,Negative Regulation Of Cell Population Proliferation (GO:0008285),13 of 379,9.335059085336011e-05,0.0082568597609797,0,0,3.793715846994536,35.20245217446387,BTG2;BTG1;CXCL8;ITGA1;CIB1;INHBA;SOD2;BMP5;SLC9A3R1;FTH1;IRF1;B2M;S100A11
1730,GO_Biological_Process_2023,T-helper Cell Lineage Commitment (GO:0002295),3 of 10,0.00010413357255158714,0.0085340433114991,0,0,44.191964285714285,405.2330708264109,SOCS3;STAT3;JAK1
1731,GO_Biological_Process_2023,Regulation Of Immune Response (GO:0050776),6 of 77,0.0001061328167625677,0.0085340433114991,0,0,8.823608316566062,80.7432449247012,PLSCR1;BCL6;IRF1;SPPL2A;BIRC3;NFE2L2
1732,GO_Biological_Process_2023,Regulation Of Cell Communication (GO:0010646),5 of 49,0.0001126701134573576,0.0086658013350463,0,0,11.81877990430622,107.44507601450798,SOCS2;PTPN1;ITGAV;TYMP;CDC42SE2
1733,GO_Biological_Process_2023,Positive Regulation Of Endothelial Cell Migration (GO:0010595),6 of 85,0.00018356501526059252,0.0133157561507078,0,0,7.926863572433192,68.19434475439361,RRAS;TMSB4X;ZC3H12A;CALR;MAPK14;HIF1A
1734,GO_Biological_Process_2023,Positive Regulation Of Regulated Secretory Pathway (GO:1903307),3 of 12,0.0001881819693429603,0.0133157561507078,0,0,34.36805555555556,294.8126565830284,SLC4A8;SYT4;RAB27A
1735,GO_Biological_Process_2023,Regulation Of Phagocytosis (GO:0050764),5 of 58,0.0002522151780816138,0.0171603326933221,0,0,9.807348560079443,81.2561184399415,PLSCR1;RAB27A;ITGAV;CALR;TGM2
1736,GO_Biological_Process_2023,Negative Regulation Of Mitotic Cell Cycle (GO:0045930),4 of 34,0.0003231885891220631,0.0211748375613677,0,0,13.804537521815009,110.95085793122124,SLC9A3R1;BTG2;BTG1;BCL6
1737,GO_Biological_Process_2023,Regulation Of Cardiac Muscle Contraction (GO:0055117),4 of 35,0.0003621264146248006,0.0228786295525454,0,0,13.35855429826043,105.84673468832496,CHGA;ZC3H12A;ATP1B1;CALM2
1738,GO_Biological_Process_2023,Regulation Of Defense Response (GO:0031347),6 of 97,0.00037661306025887583,0.0229733966757914,0,0,6.877376591662306,54.22324705104303,BCL6;TMSB4X;IRF1;CASP4;NFE2L2;BIRC3
1739,GO_Biological_Process_2023,Cellular Response To Virus (GO:0098586),5 of 64,0.0004003405266213184,0.023606746386437,0,0,8.807314897413024,68.90134236619328,IFNGR2;ZC3H12A;MAPK14;HIF1A;JAK1
1740,GO_Biological_Process_2023,Regulation Of Cell Adhesion (GO:0030155),7 of 144,0.0005366316774109403,0.0295203895893119,0,0,5.345395247709272,40.25188774740533,CXCL8;C2CD4A;C2CD4B;ITGAV;EFNA5;TGM2;RND1
1741,GO_Biological_Process_2023,Positive Regulation Of Inflammatory Response (GO:0050729),6 of 104,0.0005467076318976923,0.0295203895893119,0,0,6.383867832847424,47.95303858164846,NFKBIA;VAMP8;TNIP1;CASP4;C2CD4A;C2CD4B
1742,GO_Biological_Process_2023,Negative Regulation Of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902176),3 of 17,0.0005611149954426585,0.0295203895893119,0,0,22.088169642857142,165.3428645193843,SOD2;HIF1A;NFE2L2
1743,GO_Biological_Process_2023,Regulation Of Endopeptidase Activity (GO:0052548),5 of 69,0.0005673788841360128,0.0295203895893119,0,0,8.1171875,60.67178201730995,SERPINB1;PSME1;PSME2;TIMP1;BIRC3
1744,GO_Biological_Process_2023,3'-UTR-mediated mRNA Stabilization (GO:0070935),3 of 18,0.0006685205322407612,0.0331628829294599,0,0,20.61458333333333,150.70174566233453,RBM47;ZFP36;MAPK14
1745,GO_Biological_Process_2023,Regulation Of ERK1 And ERK2 Cascade (GO:0070372),9 of 244,0.0006748806022953982,0.0331628829294599,0,0,4.029512697323267,29.41937053140397,DDR1;PTPN1;SLC9A3R1;ADCYAP1;RRAS;TNIP1;CIB1;YWHAZ;ICAM1
1746,GO_Biological_Process_2023,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),4 of 44,0.000876856430092746,0.0410253522326812,0,0,10.348167539267015,72.84248239903246,RBM47;CASP4;AGPAT2;HIF1A
1747,GO_Biological_Process_2023,Regulation Of Protein Deubiquitination (GO:0090085),2 of 5,0.0009276507005693904,0.0410253522326812,0,0,68.40069084628671,477.63212634540446,TNIP1;ZC3H12A
1748,GO_Biological_Process_2023,Intracellular Oxygen Homeostasis (GO:0032364),2 of 5,0.0009276507005693904,0.0410253522326812,0,0,68.40069084628671,477.63212634540446,SOD2;HIF1A
1749,GO_Biological_Process_2023,Negative Regulation Of Trophoblast Cell Migration (GO:1901164),2 of 5,0.0009276507005693904,0.0410253522326812,0,0,68.40069084628671,477.63212634540446,CALR;TIMP1
1750,GO_Biological_Process_2023,Cytokine-Mediated Signaling Pathway (GO:0019221),9 of 257,0.0009741197201909072,0.0420297020736028,0,0,3.815751821019771,26.458332868654605,NFKBIA;STAT5B;SOCS1;CXCL8;TMSB4X;STAT3;JAK1;BIRC3;IL13RA1
1751,GO_Biological_Process_2023,Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),4 of 46,0.0010382027861446,0.042711179736975,0,0,9.854400398903016,67.70233378963894,ZC3H12A;STAT3;MAPK14;HIF1A
1752,GO_Biological_Process_2023,Positive Regulation Of Blood Vessel Endothelial Cell Migration (GO:0043536),4 of 46,0.0010382027861446,0.042711179736975,0,0,9.854400398903016,67.70233378963894,TMSB4X;CIB1;MAPK14;HIF1A
1753,GO_Biological_Process_2023,Regulation Of Lipid Storage (GO:0010883),3 of 21,0.0010664230194358,0.0428750527586802,0,0,17.17621527777778,117.54448805209928,NFKBIA;ZC3H12A;ITGAV
1754,GO_Biological_Process_2023,Positive Regulation Of Angiogenesis (GO:0045766),6 of 119,0.0011086762507572,0.0435832952797702,0,0,5.532237673830594,37.64460108816871,BTG1;CXCL8;RRAS;ZC3H12A;HIF1A;JAK1
1755,GO_Biological_Process_2023,Regulation Of Regulatory T Cell Differentiation (GO:0045589),3 of 22,0.0012259869245403,0.0465666602754578,0,0,16.27138157894737,109.08349028325718,SOCS1;BCL6;IRF1
1756,GO_Biological_Process_2023,Regulation Of Entry Of Bacterium Into Host Cell (GO:2000535),2 of 6,0.0013825475390542,0.0465666602754578,0,0,51.2979274611399,337.7367023754556,CXCL8;ITGAV
1757,GO_Biological_Process_2023,Autophagosome Membrane Docking (GO:0016240),2 of 6,0.0013825475390542,0.0465666602754578,0,0,51.2979274611399,337.7367023754556,VAMP8;VMP1
1758,GO_Biological_Process_2023,Cellular Response To Interleukin-9 (GO:0071355),2 of 6,0.0013825475390542,0.0465666602754578,0,0,51.2979274611399,337.7367023754556,STAT3;JAK1
1759,GO_Biological_Process_2023,Dense Core Granule Cytoskeletal Transport (GO:0099519),2 of 6,0.0013825475390542,0.0465666602754578,0,0,51.2979274611399,337.7367023754556,SYT4;KIF5B
1760,GO_Biological_Process_2023,Interleukin-9-Mediated Signaling Pathway (GO:0038113),2 of 6,0.0013825475390542,0.0465666602754578,0,0,51.2979274611399,337.7367023754556,STAT3;JAK1
1761,GO_Biological_Process_2023,Negative Regulation Of Catecholamine Secretion (GO:0033604),2 of 6,0.0013825475390542,0.0465666602754578,0,0,51.2979274611399,337.7367023754556,CHGA;SYT4
1762,GO_Biological_Process_2023,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),3 of 23,0.0013998204927834,0.0465666602754578,0,0,15.45703125,101.5745093573338,PEA15;BMP5;ICAM1
1763,GO_Biological_Process_2023,Intracellular Iron Ion Homeostasis (GO:0006879),4 of 50,0.001421480867651,0.0465666602754578,0,0,8.995674937400409,58.97614942310349,FTH1;B2M;SLC39A14;CP
1764,GO_Biological_Process_2023,Regulation Of Response To External Stimulus (GO:0032101),6 of 127,0.0015492212260466,0.0498285881613905,0,0,5.164370982552801,33.41349528090327,BCL6;TMSB4X;IRF1;CASP4;NFE2L2;BIRC3
